| Biotechnology Industry | Healthcare Sector | Mr. Jian Hua Bao CEO | XSHE Exchange | CNE1000024Z7 ISIN |
| CN Country | 1,774 Employees | 8 Jul 2021 Last Dividend | 3 Jul 2018 Last Split | - IPO Date |
Jiangxi Fushine Pharmaceutical Co., Ltd., founded in 2002 and headquartered in Jingdezhen, China, is a prominent player in the pharmaceutical sector with a global presence. The company is dedicated to the research, development, manufacture, and sale of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. Initially established as Jingdezhen Fuxiang Pharmaceutical Co., Ltd, it underwent a name change to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012 to better reflect its expanding capabilities and strategic direction. Fushine also offers a broad range of contract services, spanning research, development, and manufacturing, indicating its versatility in the pharmaceutical industry. Moreover, the company has ventured into providing additives for lithium battery electrolytes, showcasing its adaptability and innovation in meeting the diverse needs of its customers both in China and internationally.
As one of its key products, Jiangxi Fushine Pharmaceutical Co., Ltd. specializes in the production of various penicillin-based antibiotics. These antibiotics are essential in fighting a wide array of bacterial infections, reinforcing the company's role in supporting global healthcare efforts.
Fushine produces carbapenems, a class of highly effective antibiotics used to treat severe or high-risk bacterial infections. This underscores the company's commitment to addressing critical healthcare challenges and providing solutions for hard-to-treat conditions.
The company also manufactures intermediates for antiviral drugs, playing a crucial role in the supply chain for medications that are instrumental in the fight against viral epidemics and pandemics.
Fushine provides comprehensive contract services encompassing research, development, and manufacturing for partners across the globe. These services enable clients to leverage Fushine's expertise in pharmaceutical development and manufacturing, ensuring high-quality outcomes and efficiency in bringing products to market.
Expanding beyond its pharmaceutical roots, Jiangxi Fushine Pharmaceutical Co., Ltd. has ventured into the production of additives for lithium battery electrolytes. This diversification exemplifies the company’s innovation and its ability to adapt its research and manufacturing capabilities beyond the bounds of the traditional pharmaceutical industry, catering to the growing demand in the energy sector.